These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Differences between paranoid and nonparanoid schizophrenic patients on the somatosensory P300 event-related potential. Louzã MR; Maurer K Neuropsychobiology; 1989; 21(2):59-66. PubMed ID: 2615924 [TBL] [Abstract][Full Text] [Related]
9. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients. Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918 [TBL] [Abstract][Full Text] [Related]
10. The dexamethasone suppression test and negative symptoms of schizophrenia. McGauley GA; Aldridge CR; Fahy TA; Eastment C Acta Psychiatr Scand; 1989 Dec; 80(6):548-53. PubMed ID: 2618777 [TBL] [Abstract][Full Text] [Related]
11. Growth hormone response to clonidine in neuroleptic-free patients with multidagnostically defined schizophrenia. Keks NA; Copolov DL; McKenzie DP; Kulkarni J; Hassett A; Matheson B; Hill C; Mackie B; Singh B; Hirt J Psychiatry Res; 1993 Jul; 48(1):79-90. PubMed ID: 8416019 [TBL] [Abstract][Full Text] [Related]
12. Subtypes of schizophrenia--evidence from a twin-family study. Onstad S; Skre I; Torgersen S; Kringlen E Acta Psychiatr Scand; 1991 Aug; 84(2):203-6. PubMed ID: 1950618 [TBL] [Abstract][Full Text] [Related]
13. Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study. Albayrak Y; Ünsal C; Beyazyüz M; Ünal A; Kuloğlu M Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():144-9. PubMed ID: 23657077 [TBL] [Abstract][Full Text] [Related]
14. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale. Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068 [TBL] [Abstract][Full Text] [Related]
15. Free and conjugated plasma homovanillic acid in schizophrenic patients. Garcia A; Galinowski A; Guicheney P; Mignot E; Loo H; Meyer P Biol Psychiatry; 1989 May; 26(1):87-96. PubMed ID: 2720023 [TBL] [Abstract][Full Text] [Related]
16. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309 [TBL] [Abstract][Full Text] [Related]
17. Concentrations of beta-phenylethylamine in plasma and plateletes of schizophrenics. Myojin T; Taga C; Tsuji M Jpn J Psychiatry Neurol; 1989 Jun; 43(2):171-6. PubMed ID: 2796027 [TBL] [Abstract][Full Text] [Related]
18. Validity of specific subscales of the positive and negative symptom scales in older schizophrenia outpatients. McAdams LA; Harris MJ; Heaton SC; Bailey A; Fell R; Jeste DV Schizophr Res; 1997 Oct; 27(2-3):219-26. PubMed ID: 9416651 [TBL] [Abstract][Full Text] [Related]
19. Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms. Sumiyoshi T; Anil AE; Jin D; Jayathilake K; Lee M; Meltzer HY Int J Neuropsychopharmacol; 2004 Mar; 7(1):1-8. PubMed ID: 14720317 [TBL] [Abstract][Full Text] [Related]
20. [Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales]. Schaeffer E; Wciórka J Psychiatr Pol; 2003; 37(2):293-314. PubMed ID: 12776660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]